Wanes D, Al Aoua S, Shammas H, Walters F, Das A, Rizk S
Int J Mol Sci. 2024; 25(21).
PMID: 39518914
PMC: 11547104.
DOI: 10.3390/ijms252111361.
Tsikandelova R, Galo E, Cerniauskas E, Hallam D, Georgiou M, Cerna-Chavez R
Stem Cell Reports. 2024; 19(8):1107-1121.
PMID: 38964324
PMC: 11368688.
DOI: 10.1016/j.stemcr.2024.06.002.
Bruno F, Camuso S, Capuozzo E, Canterini S
Antibiotics (Basel). 2023; 12(1).
PMID: 36671323
PMC: 9855188.
DOI: 10.3390/antibiotics12010122.
Pavlova E, Lev D, Michelson M, Yosovich K, Michaeli H, Bright N
Hum Mutat. 2022; 43(12):2265-2278.
PMID: 36153662
PMC: 10091966.
DOI: 10.1002/humu.24479.
Prat Castro S, Kudrina V, Jaslan D, Bock J, Rosato A, Grimm C
Cells. 2022; 11(18).
PMID: 36139381
PMC: 9496660.
DOI: 10.3390/cells11182807.
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.
Arevalo N, Lamaizon C, Cavieres V, Burgos P, Alvarez A, Yanez M
Front Mol Neurosci. 2022; 15:934820.
PMID: 35992201
PMC: 9381931.
DOI: 10.3389/fnmol.2022.934820.
TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann-Pick type C1, and Batten disease.
Rosato A, Krogsaeter E, Jaslan D, Abrahamian C, Montefusco S, Soldati C
EMBO Mol Med. 2022; 14(9):e15377.
PMID: 35929194
PMC: 9449600.
DOI: 10.15252/emmm.202115377.
A New Hypothesis for Alzheimer's Disease: The Lipid Invasion Model.
Rudge J
J Alzheimers Dis Rep. 2022; 6(1):129-161.
PMID: 35530118
PMC: 9028744.
DOI: 10.3233/ADR-210299.
Sphingolipid lysosomal storage diseases: from bench to bedside.
Abed Rabbo M, Khodour Y, Kaguni L, Stiban J
Lipids Health Dis. 2021; 20(1):44.
PMID: 33941173
PMC: 8094529.
DOI: 10.1186/s12944-021-01466-0.
Assessing the role of glycosphingolipids in the phenotype severity of Fabry disease mouse model.
Jabbarzadeh-Tabrizi S, Boutin M, Day T, Taroua M, Schiffmann R, Auray-Blais C
J Lipid Res. 2020; 61(11):1410-1423.
PMID: 32868283
PMC: 7604726.
DOI: 10.1194/jlr.RA120000909.
Developments in the treatment of Fabry disease.
van der Veen S, Hollak C, van Kuilenburg A, Langeveld M
J Inherit Metab Dis. 2020; 43(5):908-921.
PMID: 32083331
PMC: 7540041.
DOI: 10.1002/jimd.12228.
Lysosomal size matters.
de Araujo M, Liebscher G, Hess M, Huber L
Traffic. 2019; 21(1):60-75.
PMID: 31808235
PMC: 6972631.
DOI: 10.1111/tra.12714.
ATP6V0d2 controls Leishmania parasitophorous vacuole biogenesis via cholesterol homeostasis.
Pessoa C, Reis L, Ramos-Sanchez E, Orikaza C, Cortez C, de Castro Levatti E
PLoS Pathog. 2019; 15(6):e1007834.
PMID: 31199856
PMC: 6594656.
DOI: 10.1371/journal.ppat.1007834.
The lysosomal disease caused by mutant VPS33A.
Pavlova E, Shatunov A, Wartosch L, Moskvina A, Nikolaeva L, Bright N
Hum Mol Genet. 2019; 28(15):2514-2530.
PMID: 31070736
PMC: 6644154.
DOI: 10.1093/hmg/ddz077.
Genetics and Therapies for GM2 Gangliosidosis.
Cachon-Gonzalez M, Zaccariotto E, Cox T
Curr Gene Ther. 2018; 18(2):68-89.
PMID: 29618308
PMC: 6040173.
DOI: 10.2174/1566523218666180404162622.
19q13.12 microdeletion syndrome fibroblasts display abnormal storage of cholesterol and sphingolipids in the endo-lysosomal system.
Zhao K, van der Spoel A, Castiglioni C, Gale S, Fujiwara H, Ory D
Biochim Biophys Acta Mol Basis Dis. 2018; 1864(6 Pt A):2108-2118.
PMID: 29580926
PMC: 6394866.
DOI: 10.1016/j.bbadis.2018.03.020.
Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.
Solomon M, Muro S
Adv Drug Deliv Rev. 2017; 118:109-134.
PMID: 28502768
PMC: 5828774.
DOI: 10.1016/j.addr.2017.05.004.
Lipids, lysosomes, and autophagy.
Jaishy B, Abel E
J Lipid Res. 2016; 57(9):1619-35.
PMID: 27330054
PMC: 5003162.
DOI: 10.1194/jlr.R067520.
Hepatitis C Virus Selectively Alters the Intracellular Localization of Desmosterol.
Villareal V, Fu D, Costello D, Xie X, Yang P
ACS Chem Biol. 2016; 11(7):1827-33.
PMID: 27128812
PMC: 5025300.
DOI: 10.1021/acschembio.6b00324.
A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
Rappaport J, Manthe R, Solomon M, Garnacho C, Muro S
Mol Pharm. 2015; 13(2):357-368.
PMID: 26702793
PMC: 4936955.
DOI: 10.1021/acs.molpharmaceut.5b00542.
